All News

Coronavirus: the Inter-Ministerial Conference on Public Health agrees on the European procurement procedure for Moderna vaccine candidate and finalizes COVID-19 vaccination strategy
Ref: AFMPS
Tags: Press ReleaseAstraZeneca BioNTech CureVac J&J Moderna PfizerCOVID-19 Immunisation EMA European Commission AFMPS FAMHPMarketing & Sales Regulatory Affairs
Researchers urge priority vaccination for individuals with diabetes due to increased COVID-19 impact
Ref: Vanderbilt University Medical Center
Tags: Press ReleaseDiabetes COVID-19 Immunisation Clinical Research (R&D)
Clover's adjuvanted S-Trimer COVID-19 vaccines trigger strong immune response in early study
Ref: Financial Post, Bloomberg, Business Wire
Tags: Top StoryClover Biopharmaceuticals Dynavax GSKCOVID-19 Immunisation Clinical Research (R&D)
Galapagos increases share capital through subscription right exercises
Ref: GlobeNewswire
Tags: Press ReleaseGalapagos Corporate Affairs
New pathway in development of Alzheimer’s disease discovered, providing earlier target for potential therapeutics
Ref: Newswise
Tags: Press ReleaseDementia Clinical Research (R&D)
Galectin Therapeutics Inc. Recaps Results of Annual Meeting of Stockholders Presentation
Ref: GlobeNewswire
Tags: Press ReleaseGalectin Therapeutics Corporate Affairs
Providence Therapeutics Submits Clinical Trial Application (CTA) to Health Canada for the mRNA COVID vaccine
Ref: CNW
Tags: Press ReleaseProvidence TherapeuticsCOVID-19 Immunisation Health CanadaRegulatory AffairsPTX-COVID19-B
NIH researchers link cases of ALS and FTD to a mutation associated with Huntington’s disease | National Institutes of Health (NIH)
Ref: NIH
Tags: Press ReleaseDementia NIHClinical Research (R&D)
Peanut allergy treatment significantly lowers risk of life-threatening reactions in preschoolers
Ref: University of British Columbia
Tags: Press ReleaseAllergies Clinical Research (R&D)epinephrine
Cosmo Pharmaceuticals announces licence of Lumeblue (Methylene Blue MMX) China rights to China Medical System Holdings Ltd.
Ref: Cosmo Pharmaceuticals
Tags: Press ReleaseCosmo Pharmaceuticals Corporate Affairs LicensingLuMeBlue